Towards Healthcare
Diabetes Drugs Market Size, Shares & 6.7% CAGR Rise by 2034

Diabetes Drugs Market Size to Capture USD 134.73 Bn by 2034

The diabetes drugs market is growing due to the rising global prevalence of diabetes, with over 537 million adults affected. Factors driving this growth include increased R&D, government policies, public-private partnerships, and technological advancements. More than 75% of diabetics live in low- or middle-income countries.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Diabetes Drugs Market Assessment

  • Overview
  • Global Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Insulin
    • DPP- 4 Inhibitors
    • GLP-1 Receptor Agonists
    • SGLT2 Inhibitors
  • Global Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Diabetes Type (2021 – 2033)
    • Type 1
    • Type 2
  • Global Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Subcutaneous
    • Intravenous
  • Global Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies
  • Global Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa

North America Diabetes Drugs Market Assessment

  • Overview
  • North America Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Insulin
    • DPP- 4 Inhibitors
    • GLP-1 Receptor Agonists
    • SGLT2 Inhibitors
  • North America Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Diabetes Type (2021 – 2033)
    • Type 1
    • Type 2
  • North America Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Subcutaneous
    • Intravenous
  • North America Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies

Europe Diabetes Drugs Market Assessment

  • Overview
  • Europe Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Insulin
    • DPP- 4 Inhibitors
    • GLP-1 Receptor Agonists
    • SGLT2 Inhibitors
  • Europe Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Diabetes Type (2021 – 2033)
    • Type 1
    • Type 2
  • Europe Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Subcutaneous
    • Intravenous
  • Europe Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies

Asia-Pacific Diabetes Drugs Market Assessment

  • Overview
  • Asia-Pacific Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Insulin
    • DPP- 4 Inhibitors
    • GLP-1 Receptor Agonists
    • SGLT2 Inhibitors
  • Asia-Pacific Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Diabetes Type (2021 – 2033)
    • Type 1
    • Type 2
  • Asia-Pacific Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Subcutaneous
    • Intravenous
  • Asia-Pacific Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies

Latin America Diabetes Drugs Market Assessment

  • Overview
  • Latin America Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Insulin
    • DPP- 4 Inhibitors
    • GLP-1 Receptor Agonists
    • SGLT2 Inhibitors
  • Latin America Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Diabetes Type (2021 – 2033)
    • Type 1
    • Type 2
  • Latin America Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Subcutaneous
    • Intravenous
  • Latin America Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies

Middle East and Africa Diabetes Drugs Market Assessment

  • Overview
  • Middle East and Africa Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Insulin
    • DPP- 4 Inhibitors
    • GLP-1 Receptor Agonists
    • SGLT2 Inhibitors
  • Middle East and Africa Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Diabetes Type (2021 – 2033)
    • Type 1
    • Type 2
  • Middle East and Africa Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Subcutaneous
    • Intravenous
  • Middle East and Africa Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies

Company Profiles

  • Novo Nordisk A/s
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Sanofi
  • Merck & Co, Inc
  • Eli Lilly and Company
  • AstraZeneca
  • Takeda Pharmaceuticals Company Limited
  • Boehringer Ingelheim International GmbH 
  • Novartis AG
  • Johnson & Johnson Services, Inc.
  • Bayer AG

Conclusion & Recommendations

  • Insight Code: 5055
  • No. of Pages: 150
  • Format: PDF/PPT/Excel
  • Published: November 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

Factors such as the increasing prevalence of diabetes, rising awareness and diagnosis, advancements in drug delivery systems, and the growing geriatric population are contributing to the growth of the diabetes drugs market.

Lifestyle modifications, including adopting a healthy diet, regular physical activity, weight management, and smoking cessation, play a crucial role in diabetes management alongside medication.

Generic drugs provide cost-effective alternatives to branded drugs, increasing affordability and accessibility for patients. They also foster competition and drive down prices in the market.

U.S. Department of Health & Human Services, International Diabetes Federation, and World health Organization

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 509

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 509